Assessment of selected serum inflammatory markers of acute phase response and their correlations with adrenal androgens and metabolic syndrome in a population of men over the age of 40

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 11, 2009, Pages 704-711

  Herman, Waldemar A ^a   Seńko, Aleksandra ^b   Korczowska, Izabela ^b   Ła̧cka, Katarzyna ^b  

^a Poradnia Endokrynologiczna HERMED   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adrenal androgens; Aging men; C reactive protein; Transferrin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ANDROGEN; C REACTIVE PROTEIN; PRASTERONE; PRASTERONE SULFATE; TRANSFERRIN;

ACUTE PHASE RESPONSE; ADRENAL GLAND; ADULT; AGED; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CIGARETTE SMOKING; DISEASE MARKER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLAND; PROGNOSIS;

EID: 72149095112     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.817     Document Type: Article

References (35)

1. Oevaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009; 20: 182-189.
2. Jawień J. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn. 2008; 118: 127-131.
3. Ridker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem. 2009; 55: 209-215.
4. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proin-flammatory state. Blood. 2005; 105: 2294-2299. (Pubitemid 40387022)
5. Ritchie RF, Palomaki GE, Neveux LM, et al. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal. 1999; 13: 273-279.
6. Tillen WS, Francis Jr T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930; 52: 561-571.
7. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111: 1805-1812.
8. Kalsheker NA. Alpha 1-antichymotrypsin. Int J Biochem Cell Biol. 1996; 28: 961-964.
9. Świa̧tkowska-Stodulska R, Babińska A, Skibowska-Bielińska A, Sworczak K. Assessment of alpha 1-antitrypsin and alpha2-macroglobulin levels in obese patients. Pol Arch Med Wewn. 2008; 118: 713-718.
10. Ritchie RF, Palomaki GE, Neveux LM et al. Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal. 2002; 16: 237-245.
11. Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke. 2005; 36: 2138-2142. (Pubitemid 41429234)
12. Albuquerque LC, Narvaes LB, Maciel AA, et al. Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis. J Vasc Surg. 2007; 46: 1130-1137. (Pubitemid 350284643)
13. Nakhai-Pour HR, Grobbee DE, Bots ML, et al. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community. J Hum Hypertens. 2007; 21: 949-955.
14. Hosseinsabet A, Mohebbi A, Almasi A. C-reactive protein and coronary calcium score association in coronary artery disease. Cardiol J. 2008; 15: 431-436.
15. Milewicz A, Sieradzki J, Jȩdrzejuk D. ("To be or not to be" of metabolic syndrome]. Pol Arch Med Wewn. 2006; 115: 191-196. Polish.
16. Taaffe DR, Harris TB, Ferrucci L, et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000; 55: 709-715.
17. Rutter MK, Meigs JB, Sullivan LM, et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110: 380-385.
18. Maseri A. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out. Ital Heart J. 2001; 2: 155-156.
19. Bo M, Corsinovi L, Brescianini A, et al. High-sensitivity C-reactive protein is not independently associated with peripheral subclinical atherosclerosis. Angiology. 2009; 60: 12-20.
20. Tannenbaum C, Barrett-Connor E, Laughlin GA, et al. A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study. Eur J Endocrinol. 2004; 151: 717-725. (Pubitemid 40090011)
21. liyama K, Nagano M, Nagano N, et al. [Risk factors related to the wall thickness of carotid artery assessed by ultrasonography). Nippon Ronen lgakkai Zasshi. 1994; 31: 303-309. Japanese.
22. Executive summary of the third report of the national cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 2001; 285: 2486-2497.
23. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966; 15: 45-52.
24. Cankurtaran M, Halil M, Yavuz BB, et al. Prevalence and correlates of metabolic syndrome in older adults. Arch Gerontol Geriatr. 2006; 42: 35-45. (Pubitemid 41579096)
25. Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003; 149: 601-608. (Pubitemid 38054707)
26. Straub RH, Lehle K, Herfath H, et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumor necrosis factor. Eur J Endocrinol. 2002; 146: 365-374. (Pubitemid 34257647)
27. Nakhai Pour HR, Grobbee DE, Muller M, van der Schouw YT. Association of endogenous sex hormone with C-reactive protein levels in middle--aged and elderly men. Clin Endocrinol (Oxf). 2007; 66: 394-398. (Pubitemid 46239299)
28. Muller M, Grobbee DE, den Tonkelaar I, et al. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005, 90: 2618-2623. (Pubitemid 40686299)
29. Araújo F, Pereira AC, Latorre Mdo R, et al. High-sensitivity C-reactive protein concentration in a healthy Brazilian population. Int J Cardiol. 2004; 97: 433-1348 (Pubitemid 39550692)
30. Zdrojewski T, Wyrzykowski B, Szczech R, et al. Epidemiology and prevention of arterial hypertension in Poland. Blood Press Suppl. 2005; 2: 10-16. (Pubitemid 43173239)
31. Herman WA, Seńko A, Korczowska I, Łacka K. (Could serum DHEA and DHEAS levels be good risk predictors of metabolic syndrome and osteoporosis in the population of ageing men?) Pol Merkur Lekarski. 2009; 159: 197-201. Polish.
32. Dupuy AM, Jaussent I, Lacrous A, et al. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Gerontology. 2007; 53: 329-339. (Pubitemid 351664657)
33. Lear SA, Chen MM, Birmingham CL, Frohlich JJ. The relationships between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism. 2003; 52: 1542-1546.
34. Wannamethee SG, Lowe GO, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005; 26: 1765-1773.
35. Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2413-2418.